BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Andina D, Noguera-Morel L, Bascuas-Arribas M, Gaitero-Tristán J, Alonso-Cadenas JA, Escalada-Pellitero S, Hernández-Martín Á, de la Torre-Espi M, Colmenero I, Torrelo A. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol 2020;37:406-11. [PMID: 32386460 DOI: 10.1111/pde.14215] [Cited by in Crossref: 98] [Cited by in F6Publishing: 88] [Article Influence: 49.0] [Reference Citation Analysis]
Number Citing Articles
1 Dondi A, Sperti G, Gori D, Guaraldi F, Montalti M, Parini L, Piraccini BM, Lanari M, Neri I. Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological lesions in pediatric patients affected by SARS-CoV-2 infection: A systematic review of the literature. Eur J Pediatr 2022. [PMID: 35948654 DOI: 10.1007/s00431-022-04585-7] [Reference Citation Analysis]
2 De Alwis AC, Kapuwatte S. Pre-school girl with bluish purple fingers. J Paediatr Child Health 2022. [PMID: 35778997 DOI: 10.1111/jpc.16075] [Reference Citation Analysis]
3 Fennell J, Onel K. Chilblains-Like Lesions in Pediatric Patients: A Review of Their Epidemiology, Etiology, Outcomes, and Treatment. Front Pediatr 2022;10:904616. [DOI: 10.3389/fped.2022.904616] [Reference Citation Analysis]
4 Pasquini Neto R, Mazzo FAT, Vieira FA, Bueno GS, Previdi JVC, Silva LRD, Silva NKBD, Jorizzo JL, Cerci FB. COVID-19 cutaneous manifestations in children and adolescents: a systematic review. Rev Paul Pediatr 2022;40:e2021134. [PMID: 35703724 DOI: 10.1590/1984-0462/2022/40/2021134IN] [Reference Citation Analysis]
5 Hodge B, Daniel CR, Elewski BE. Vaccine Toes Are the New COVID Toes. Skin Appendage Disord 2022;37:1-4. [PMID: 35664444 DOI: 10.1159/000521724] [Reference Citation Analysis]
6 Bascuas-Arribas M, Andina-Martinez D, Añon-Hidalgo J, Alonso-Cadenas JA, Hernandez-Martin A, Lamagrande-Casanova N, Noguero-Morel L, Mateos-Mayo A, Colmenero-Blanco I, Torrelo A. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic. Pediatr Dermatol 2022. [PMID: 35129855 DOI: 10.1111/pde.14948] [Reference Citation Analysis]
7 André R, Hsieh A, Trellu LT. Chronic Acral Lesions (“COVID Toes”): To Add to Long Post- COVID-19 Syndrome? Angiology. [DOI: 10.1177/00033197211068938] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pasquini Neto R, Mazzo FAT, Vieira FDA, Bueno GDS, Previdi JVC, Silva LRD, Silva NKBD, Jorizzo JL, Cerci FB. Manifestações cutâneas da COVID-19 em crianças e adolescentes: uma revisão sistemática. Rev paul pediatr 2022;40:e2021134. [DOI: 10.1590/1984-0462/2022/40/2021134] [Reference Citation Analysis]
9 Dinulos JE, Dinulos JG. Cutaneous coronavirus disease 2019 in children: a clinical primer for diagnosis and treatment. Curr Opin Pediatr 2021;33:691-703. [PMID: 34670262 DOI: 10.1097/MOP.0000000000001076] [Reference Citation Analysis]
10 Magro C, Nuovo G, Mulvey JJ, Laurence J, Harp J, Crowson AN. The skin as a critical window in unveiling the pathophysiologic principles of COVID-19. Clinics in Dermatology 2021;39:934-65. [DOI: 10.1016/j.clindermatol.2021.07.001] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Akuffo-Addo E, Nicholas MN, Joseph M. COVID-19 Skin Manifestations in Skin of Colour. J Cutan Med Surg 2021;:12034754211053310. [PMID: 34663122 DOI: 10.1177/12034754211053310] [Reference Citation Analysis]
12 Bakos RM, Leite LL, Reinehr C, Escobar GF. Dermoscopy of skin infestations and infections (entomodermoscopy) - Part II: viral, fungal and other infections. An Bras Dermatol 2021;96:746-58. [PMID: 34620527 DOI: 10.1016/j.abd.2021.04.008] [Reference Citation Analysis]
13 Berrebi D, Farmer W, Zinn Z. BASCULE syndrome in a child with prior asymptomatic COVID-19 infection. Pediatr Dermatol 2021;38:1342-4. [PMID: 34595767 DOI: 10.1111/pde.14821] [Reference Citation Analysis]
14 Agnihothri R, Fox LP. Clinical Patterns and Morphology of COVID-19 Dermatology. Dermatol Clin 2021;39:487-503. [PMID: 34556240 DOI: 10.1016/j.det.2021.05.006] [Reference Citation Analysis]
15 Neale H, Hawryluk EB. COVID-19 Pediatric Dermatology. Dermatol Clin 2021;39:505-19. [PMID: 34556241 DOI: 10.1016/j.det.2021.05.012] [Reference Citation Analysis]
16 Sánchez-García V, Hernández-Quiles R, de-Miguel-Balsa E, Docampo-Simón A, Belinchón-Romero I, Ramos-Rincón JM. Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2022;36:24-38. [PMID: 34545625 DOI: 10.1111/jdv.17672] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 El-Hor N, Adams M. Pediatric Rheumatologic Effects of COVID-19. Pediatr Clin North Am 2021;68:1011-27. [PMID: 34538296 DOI: 10.1016/j.pcl.2021.05.002] [Reference Citation Analysis]
18 Schwartz RA, Lambert WC. COVID-19-specific skin changes related to SARS-CoV-2: Visualizing a monumental public health challenge. Clin Dermatol 2021;39:374-9. [PMID: 34517995 DOI: 10.1016/j.clindermatol.2021.01.009] [Reference Citation Analysis]
19 Dezoteux F, Mille B, Fievet C, Moreau AS, Duhamel A, Drumez E, Mathieu D, Poissy J, Staumont-Salle D, Buche S. Vascular skin manifestations in patients with severe COVID-19 in intensive care units: a monocentric prospective study. Eur J Dermatol 2021. [PMID: 34463284 DOI: 10.1684/ejd.2021.4107] [Reference Citation Analysis]
20 Farinazzo E, Dianzani C, Zalaudek I, Conforti C, Grabbe S, Goldust M. Synthesis of the Data on COVID-19 Skin Manifestations: Underlying Mechanisms and Potential Outcomes. Clin Cosmet Investig Dermatol 2021;14:991-7. [PMID: 34385830 DOI: 10.2147/CCID.S325552] [Reference Citation Analysis]
21 Vowden K, Hill L. What is the impact of COVID-19 on tissue viability services and pressure ulceration? J Wound Care 2021;30:522-31. [PMID: 34256597 DOI: 10.12968/jowc.2021.30.7.522] [Reference Citation Analysis]
22 Yilmaz MM, Szabolcs MJ, Geskin LJ, Niedt GW. An Autopsy Review: "COVID Toes". Am J Dermatopathol 2021;43:554-5. [PMID: 33055537 DOI: 10.1097/DAD.0000000000001827] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Kolivras A, Thompson C, Pastushenko I, Mathieu M, Bruderer P, de Vicq M, Feoli F, Harag S, Meiers I, Olemans C, Sass U, Dehavay F, Fakih A, Lam-Hoai XL, Marneffe A, Van De Borne L, Vandersleyen V, Richert B. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review. J Cutan Pathol 2021. [PMID: 34272741 DOI: 10.1111/cup.14099] [Reference Citation Analysis]
24 Oliva Rodríguez-Pastor S, Martín Pedraz L, Carazo Gallego B, Galindo Zavala R, Lozano Sánchez G, de Toro Peinado I, Rodriguez Benjumea M, Mejias A, Núñez Cuadros E. Skin manifestations during the COVID-19 pandemic in the pediatric emergency department. Pediatr Int 2021;63:1033-7. [PMID: 33278056 DOI: 10.1111/ped.14568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Santos JN, de Brito Chagas J, Calvão J, Estanqueiro P, Ramos L. A severe case of chilblains in late 2020: Is there something else? J Paediatr Child Health 2021. [PMID: 34231278 DOI: 10.1111/jpc.15642] [Reference Citation Analysis]
26 Seth S, Rashid F, Khera K. An overview of the COVID-19 complications in paediatric population: A pandemic dilemma. Int J Clin Pract 2021;75:e14494. [PMID: 34115913 DOI: 10.1111/ijcp.14494] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Favaloro EJ, Henry BM, Lippi G. Is Lupus Anticoagulant a Significant Feature of COVID-19? A Critical Appraisal of the Literature. Semin Thromb Hemost 2021. [PMID: 34130341 DOI: 10.1055/s-0041-1729856] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Akl J, El-Kehdy J, Salloum A, Benedetto A, Karam P. Skin disorders associated with the COVID-19 pandemic: A review. J Cosmet Dermatol 2021. [PMID: 34077629 DOI: 10.1111/jocd.14266] [Reference Citation Analysis]
29 Discepolo V, Catzola A, Pierri L, Mascolo M, Della Casa F, Vastarella M, Smith G, Travaglino A, Punziano A, Nappa P, Staibano S, Bruzzese E, Fabbrocini G, Guarino A, Alessio M. Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic. JAMA Netw Open 2021;4:e2111369. [PMID: 34110396 DOI: 10.1001/jamanetworkopen.2021.11369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Najar Nobari N, Seirafianpour F, Dodangeh M, Sadeghzadeh-Bazargan A, Behrangi E, Mozafarpoor S, Goodarzi A. A systematic review of the histopathologic survey on skin biopsies in patients with Corona Virus Disease 2019 (COVID-19) who developed virus or drug-related mucocutaneous manifestations. Exp Dermatol 2021;30:1233-53. [PMID: 33977531 DOI: 10.1111/exd.14384] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
31 Sadeghzadeh-Bazargan A, Rezai M, Najar Nobari N, Mozafarpoor S, Goodarzi A. Skin manifestations as potential symptoms of diffuse vascular injury in critical COVID-19 patients. J Cutan Pathol 2021. [PMID: 33978234 DOI: 10.1111/cup.14059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
32 Kohl S, Eifler L. [A 15-year-old girl with swollen and reddened toes]. Monatsschr Kinderheilkd 2021;:1-4. [PMID: 33903780 DOI: 10.1007/s00112-021-01190-0] [Reference Citation Analysis]
33 Papa A, Salzano AM, Di Dato MT, Lo Bianco G, Tedesco M, Salzano A, Myrcik D, Imani F, Varrassi G, Akhavan Akbari G, Paladini A. COVID-19 Related Acro-Ischemic Neuropathic-like Painful Lesions in Pediatric Patients: A Case Series. Anesth Pain Med 2021;11:e113760. [PMID: 34336629 DOI: 10.5812/aapm.113760] [Reference Citation Analysis]
34 Kashetsky N, Mukovozov IM, Bergman J. Chilblain-Like Lesions (CLL) Associated With COVID-19 ("COVID Toes"): A Systematic Review. J Cutan Med Surg 2021;:12034754211004575. [PMID: 33849305 DOI: 10.1177/12034754211004575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
35 Ingravallo G, Mazzotta F, Resta L, Sablone S, Cazzato G, Cimmino A, Rossi R, Colagrande A, Ferrante B, Troccoli T, Bonifazi E. Inflammatory Skin Lesions in Three SARS-CoV-2 Swab-Negative Adolescents: A Possible COVID-19 Sneaky Manifestation? Pediatr Rep 2021;13:181-8. [PMID: 33918585 DOI: 10.3390/pediatric13020025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
36 Palomo-Pérez JC, Vega-Memije ME, Aguilar-Blancas D, González-Martínez E, Rangel-Gamboa L. Cutaneous manifestations of COVID-19 in Mexican patients: A case series and review of literature. SAGE Open Med Case Rep 2021;9:2050313X21997194. [PMID: 33747514 DOI: 10.1177/2050313X21997194] [Reference Citation Analysis]
37 Jeyashree K, Raju M, Ponnaiah M, Muthappan S, Rozario AGA, Raichel R, Jeris WL, Gangakhedkar RR, Murhekar MV. Self-reported and clinically identified loss of smell and taste among persons tested for COVID-19 in Chennai, southern India, July-August 2020: A cross sectional study. Clin Epidemiol Glob Health 2021;11:100718. [PMID: 33754133 DOI: 10.1016/j.cegh.2021.100718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Novak N, Peng W, Naegeli MC, Galvan C, Kolm-Djamei I, Brüggen C, Cabanillas B, Schmid-Grendelmeier P, Catala A. SARS-CoV-2, COVID-19, skin and immunology - What do we know so far? Allergy 2021;76:698-713. [PMID: 32658359 DOI: 10.1111/all.14498] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 31.0] [Reference Citation Analysis]
39 Swali RN, Lee EB, Adams JL. Gianotti-crosti syndrome in the setting of recent coronavirus disease-19 infection. Pediatr Dermatol 2021;38:629-31. [PMID: 33641205 DOI: 10.1111/pde.14518] [Reference Citation Analysis]
40 Larenas-Linnemann D, Luna-Pech J, Navarrete-Rodríguez EM, Rodríguez-Pérez N, Arias-Cruz A, Blandón-Vijil MV, Del Rio-Navarro BE, Estrada-Cardona A, Onuma-Takane E, Pozo-Beltrán CF, Valencia-Herrera AM, Ortiz-Aldana FI, Toledo-Bahena ME. Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group. Curr Allergy Asthma Rep 2021;21:13. [PMID: 33630167 DOI: 10.1007/s11882-020-00986-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
41 Ladha MA, Luca N, Constantinescu C, Naert K, Ramien ML. Response to Reader Comment Regarding "Approach to Chilblains During the COVID-19 Pandemic". J Cutan Med Surg 2021;25:344-5. [PMID: 33624518 DOI: 10.1177/1203475421997405] [Reference Citation Analysis]
42 Sharma S, Raby E, Prasad Kumarasinghe S. Cutaneous manifestations and dermatological sequelae of Covid-19 infection compared to those from other viruses. Australas J Dermatol 2021;62:141-50. [PMID: 33595840 DOI: 10.1111/ajd.13561] [Reference Citation Analysis]
43 Gasparotto M, Framba V, Piovella C, Doria A, Iaccarino L. Post-COVID-19 arthritis: a case report and literature review. Clin Rheumatol 2021;40:3357-62. [PMID: 33587197 DOI: 10.1007/s10067-020-05550-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
44 Singh H, Kaur H, Singh K, Sen CK. Cutaneous Manifestations of COVID-19: A Systematic Review. Adv Wound Care (New Rochelle) 2021;10:51-80. [PMID: 33035150 DOI: 10.1089/wound.2020.1309] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 40.0] [Reference Citation Analysis]
45 Shah S, Akhade K, Ganguly S, Nanda R, Mohapatra E, Goel AK. Cutaneous manifestations associated with COVID-19 in children: A systematic review. J Family Med Prim Care 2021;10:93-101. [PMID: 34017709 DOI: 10.4103/jfmpc.jfmpc_1389_20] [Reference Citation Analysis]
46 Cappel MA, Cappel JA, Wetter DA. Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms. Mayo Clin Proc 2021;96:989-1005. [PMID: 33714595 DOI: 10.1016/j.mayocp.2021.01.009] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
47 Ganesh B, Rajakumar T, Malathi M, Manikandan N, Nagaraj J, Santhakumar A, Elangovan A, Malik YS. Epidemiology and pathobiology of SARS-CoV-2 (COVID-19) in comparison with SARS, MERS: An updated overview of current knowledge and future perspectives. Clin Epidemiol Glob Health 2021;10:100694. [PMID: 33462564 DOI: 10.1016/j.cegh.2020.100694] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
48 Koschitzky M, Oyola RR, Lee-Wong M, Abittan B, Silverberg N. Pediatric COVID toes and fingers. Clin Dermatol 2021;39:84-91. [PMID: 33972057 DOI: 10.1016/j.clindermatol.2020.12.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
49 Rodriguez-Cerdeira C, Uribe-Camacho BI, Silverio-Carrasco L, Méndez W, Mahesh AR, Tejada A, Beirana A, Martinez-Herrera E, Alba A, Arenas R, Szepietowski JC. Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries. Biology (Basel) 2021;10:54. [PMID: 33451000 DOI: 10.3390/biology10010054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Hubiche T, Phan A, Leducq S, Rapp J, Fertitta L, Aubert H, Barbarot S, Chiaverini C, Giraudeau B, Lasek A, Mallet S, Labarelle A, Piram M, McCuaig C, Martin L, Monitor L, Nicol I, Bissuel M, Bellissen A, Jullien D, Lesort C, Vabres P, Maruani A; Research Group of the Société Française de Dermatologie Pédiatrique (French Society of Pediatric Dermatology). Acute acral eruptions in children during the COVID-19 pandemic: Characteristics of 103 children and their family clusters. Ann Dermatol Venereol 2021;148:94-100. [PMID: 33551211 DOI: 10.1016/j.annder.2020.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Lambert WC, Alhatem A, Lambert MW, Schwartz RA. What we have learned from the COVID-19 pandemic: Time to think outside the box, maybe far outside. Clin Dermatol 2021;39:107-17. [PMID: 33972037 DOI: 10.1016/j.clindermatol.2020.12.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Rongioletti F, Ferreli C, Sena P, Caputo V, Atzori L. Clinicopathologic correlations of COVID-19-related cutaneous manifestations with special emphasis on histopathologic patterns. Clin Dermatol 2021;39:149-62. [PMID: 33972045 DOI: 10.1016/j.clindermatol.2020.12.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
53 Novelli L, Motta F, De Santis M, Ansari AA, Gershwin ME, Selmi C. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature. J Autoimmun 2021;117:102592. [PMID: 33401171 DOI: 10.1016/j.jaut.2020.102592] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
54 Burlando M, Russo R, Cozzani E, Parodi A. Six months into the pandemic. A review of skin manifestations in SARS-CoV-2 infection. Dermatol Ther 2021;34:e14641. [PMID: 33278049 DOI: 10.1111/dth.14641] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
55 Ciechanowicz P, Lewandowski K, Szymańska E, Kaniewska M, Rydzewska GM, Walecka I. Skin and gastrointestinal symptoms in COVID-19. Prz Gastroenterol 2020;15:301-8. [PMID: 33777269 DOI: 10.5114/pg.2020.101558] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Khalili M, Iranmanesh B, Mohammadi S, Aflatoonian M. Cutaneous and histopathological features of coronavirus disease 2019 in pediatrics: A review article. Dermatol Ther 2021;34:e14554. [PMID: 33210417 DOI: 10.1111/dth.14554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
57 Conforti C, Dianzani C, Agozzino M, Giuffrida R, Marangi GF, Meo ND, Morariu SH, Persichetti P, Segreto F, Zalaudek I, Neagu N. Cutaneous Manifestations in Confirmed COVID-19 Patients: A Systematic Review. Biology (Basel) 2020;9:E449. [PMID: 33291502 DOI: 10.3390/biology9120449] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
58 Kluckow E, Krieser DM, Slaa M. COVID toes in stay-at-home adolescents: An epiphenomenon? Emerg Med Australas 2020;32:1088-90. [PMID: 32929872 DOI: 10.1111/1742-6723.13630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Naka F, Melnick L, Gorelik M, Morel KD. A dermatologic perspective on multisystem inflammatory syndrome in children. Clin Dermatol 2021;39:337-43. [PMID: 34272033 DOI: 10.1016/j.clindermatol.2020.11.005] [Reference Citation Analysis]
60 Macy ML, Huetteman P, Kan K. Changes in Primary Care Visits in the 24 Weeks After COVID-19 Stay-at-Home Orders Relative to the Comparable Time Period in 2019 in Metropolitan Chicago and Northern Illinois. J Prim Care Community Health 2020;11:2150132720969557. [PMID: 33174495 DOI: 10.1177/2150132720969557] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
61 Jindal R, Chauhan P. Cutaneous manifestations of coronavirus disease 2019 in 458 confirmed cases: A systematic review. J Family Med Prim Care 2020;9:4563-9. [PMID: 33209764 DOI: 10.4103/jfmpc.jfmpc_872_20] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
62 Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, Diociaiuti A, El-Hachem M, Fertitta L, van Gysel D, Hernández-Martín A, Hubiche T, Luca C, Martos-Cabrera L, Maruani A, Mazzotta F, Akkaya AD, Casals M, Ferrando J, Grimalt R, Grozdev I, Kinsler V, Morren MA, Munisami M, Nanda A, Novoa MP, Ott H, Pasmans S, Salavastru C, Zawar V, Torrelo A; ESPD Group for the Skin Manifestations of COVID-19. Skin manifestations of COVID-19 in children: Part 3. Clin Exp Dermatol 2021;46:462-72. [PMID: 33207021 DOI: 10.1111/ced.14483] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
63 Teoh CW, Gaudreault-Tremblay MM, Blydt-Hansen TD, Goldberg A, Arora S, Feber J, Langlois V, Ruhl M, Phan V, Morgan C, Acott P, Hamiwka L. Management of Pediatric Kidney Transplant Patients During the COVID-19 Pandemic: Guidance From the Canadian Society of Transplantation Pediatric Group. Can J Kidney Health Dis 2020;7:2054358120967845. [PMID: 33240516 DOI: 10.1177/2054358120967845] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
64 Naderi-Azad S, Vender R. Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular Patterns [Formula: see text]. J Cutan Med Surg 2021;25:169-76. [PMID: 33179534 DOI: 10.1177/1203475420972343] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
65 Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, Diociaiuti A, El-Hachem M, Fertitta L, van Gysel D, Hernández-Martín A, Hubiche T, Luca C, Martos-Cabrera L, Maruani A, Mazzotta F, Akkaya AD, Casals M, Ferrando J, Grimalt R, Grozdev I, Kinsler V, Morren MA, Munisami M, Nanda A, Novoa MP, Ott H, Pasmans S, Salavastru C, Zawar V, Torrelo A; ESPD Group for the Skin Manifestations of COVID-19. Skin manifestations of COVID-19 in children: Part 1. Clin Exp Dermatol 2021;46:444-50. [PMID: 33180982 DOI: 10.1111/ced.14481] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
66 Rubin A, Alamgir M, Rubin J, Rao BK. Chilblain-like lesions with prominent bullae in a patient with COVID-19. BMJ Case Rep 2020;13:e237917. [PMID: 33139373 DOI: 10.1136/bcr-2020-237917] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
67 Ciaffi J, Meliconi R, Ruscitti P, Berardicurti O, Giacomelli R, Ursini F. Rheumatic manifestations of COVID-19: a systematic review and meta-analysis. BMC Rheumatol 2020;4:65. [PMID: 33123675 DOI: 10.1186/s41927-020-00165-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 12.5] [Reference Citation Analysis]
68 Andina D, Colmenero I, Santonja C, Muñoz de León I, Noguera-Morel L, Hernández-Martín A, Torrelo A. Suspected COVID-19-related reticulated purpura of the soles in an infant. Pediatr Dermatol 2021;38:301-3. [PMID: 33085141 DOI: 10.1111/pde.14409] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
69 Diociaiuti A, Giancristoforo S, Terreri S, Corbeddu M, Concato C, Ciofi Degli Atti M, Zambruno G, Carsetti R, El Hachem M. Are SARS‐CoV‐2 IgA antibodies in paediatric patients with chilblain‐like lesions indicative of COVID‐19 asymptomatic or paucisymptomatic infection? J Eur Acad Dermatol Venereol 2021;35. [DOI: 10.1111/jdv.16934] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
70 Gómez-Fernández C, López-Sundh AE, González-Vela C, Ocejo-Vinyals JG, Mayor-Ibarguren A, Salas-Venero CA, Gutiérrez-Larrañaga M, Tejerina-Puente A, Fariñas MC, Cabero-Pérez MJ, López-Hoyos M, González-López MA. High prevalence of cryofibrinogenemia in patients with chilblains during the COVID-19 outbreak. Int J Dermatol 2020;59:1475-84. [PMID: 33070314 DOI: 10.1111/ijd.15234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
71 Docampo-Simón A, Sánchez-Pujol MJ, Gimeno-Gascon A, Palazón-Cabanes JC, Juan-Carpena G, Vergara-De Caso E, González-Villanueva I, Blanes-Martínez M, Betlloch-Mas I. No SARS-CoV-2 antibody response in 25 patients with pseudo-chilblains. Dermatol Ther 2020;33:e14332. [PMID: 32975345 DOI: 10.1111/dth.14332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
72 Fertitta L, Welfringer-Morin A, Ouedrani A, Polivka L, Chhun S, Chatenoud L, Fourgeaud J, Hadj-Rabia S, Temmam S, Eloit M, Sermet-Gaudelus I, Bodemer C. Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2. J Eur Acad Dermatol Venereol 2021;35:e164-7. [PMID: 33010072 DOI: 10.1111/jdv.16972] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
73 Khan L. SARS-CoV-2 Infection in Children: Special Considerations. Pediatr Ann 2020;49. [DOI: 10.3928/19382359-20200919-01] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Fabbrocini G, Vastarella M, Nappa P, Annunziata MC, Camela E, Greco V, Gaudiello F, Alessio M, Pierri L, Catzola A, Guarino A. A new dermoscopic pattern for chilblain-COVID-19-like skin lesions in adolescents. JAAD Case Rep 2020;6:1271-4. [PMID: 33020736 DOI: 10.1016/j.jdcr.2020.09.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
75 Ko CJ, Harigopal M, Gehlhausen JR, Bosenberg M, McNiff JM, Damsky W. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein. J Cutan Pathol 2021;48:47-52. [PMID: 32895985 DOI: 10.1111/cup.13866] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
76 Occidental M, Flaifel A, Lin LH, Guzzetta M, Thomas K, Jour G. Investigating the spectrum of dermatologic manifestations in COVID-19 infection in severely ill patients: A series of four cases. J Cutan Pathol 2021;48:110-5. [PMID: 32896915 DOI: 10.1111/cup.13867] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
77 Naka F, Melnick L, Gorelik M, Morel KD. A dermatologic perspective on multisystem inflammatory syndrome in children. Clin Dermatol 2021;39:163-8. [PMID: 33972046 DOI: 10.1016/j.clindermatol.2020.09.003] [Reference Citation Analysis]
78 Colmenero I, Santonja C, Alonso-Riaño M, Andina D, Rodríguez-Peralto JL, Requena L, Torrelo A. Chilblains and COVID-19: why SARS-CoV-2 endothelial infection is questioned. Reply from the authors. Br J Dermatol 2020;183:1153-4. [PMID: 32798316 DOI: 10.1111/bjd.19491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
79 Rajan M B, Kumar-M P, Bhardwaj A. The trend of cutaneous lesions during COVID-19 pandemic: lessons from a meta-analysis and systematic review. Int J Dermatol. 2020;59:1358-1370. [PMID: 32936462 DOI: 10.1111/ijd.15154] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
80 Magro CM, Mulvey JJ, Laurence J, Sanders S, Crowson AN, Grossman M, Harp J, Nuovo G. The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series. Br J Dermatol 2021;184:141-50. [PMID: 32779733 DOI: 10.1111/bjd.19415] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
81 Verma R, Amin R. Clinical pearls for COVID-19 in children: what do pediatricians need to know? Pediatr Res 2021;89:1328-30. [PMID: 32916688 DOI: 10.1038/s41390-020-01123-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Ko CJ, Harigopal M, Damsky W, Gehlhausen JR, Bosenberg M, Patrignelli R, McNiff JM. Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2. J Cutan Pathol 2020;47:997-1002. [PMID: 32745281 DOI: 10.1111/cup.13830] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
83 Talotta R, Robertson E. Autoimmunity as the comet tail of COVID-19 pandemic. World J Clin Cases 2020; 8(17): 3621-3644 [PMID: 32953841 DOI: 10.12998/wjcc.v8.i17.3621] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 28] [Article Influence: 19.0] [Reference Citation Analysis]
84 Singh P, Schwartz RA. Disseminated intravascular coagulation: A devastating systemic disorder of special concern with COVID-19. Dermatol Ther 2020;33:e14053. [PMID: 32700813 DOI: 10.1111/dth.14053] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
85 Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, Schmidt E, Schön MP, Sticherling M, Sunderkötter C, Traidl-Hoffmann C, Werfel T, Wilsman-Theis D, Worm M. COVID‐19 und Auswirkungen auf dermatologische und allergologische Erkrankungen. J Dtsch Dermatol Ges 2020;18:815-25. [PMID: 32881343 DOI: 10.1111/ddg.14195_g] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Rose-sauld S, Dua A. COVID toes and other cutaneous manifestations of COVID-19. J Wound Care 2020;29:486-7. [DOI: 10.12968/jowc.2020.29.9.486] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
87 Martinez FO, Combes TW, Orsenigo F, Gordon S. Monocyte activation in systemic Covid-19 infection: Assay and rationale. EBioMedicine 2020;59:102964. [PMID: 32861199 DOI: 10.1016/j.ebiom.2020.102964] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 13.5] [Reference Citation Analysis]
88 Le Cleach L, Dousset L, Assier H, Fourati S, Barbarot S, Boulard C, Bourseau Quetier C, Cambon L, Cazanave C, Colin A, Kostrzewa E, Lesort C, Levy Roy A, Lombart F, Marco-Bonnet J, Monfort JB, Samimi M, Tardieu M, Wolkenstein P, Sbidian E, Beylot-Barry M; French Society of Dermatology. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing. Br J Dermatol 2020;183:866-74. [PMID: 32628270 DOI: 10.1111/bjd.19377] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
89 Denina M, Pellegrino F, Morotti F, Coppo P, Bonsignori IM, Garazzino S, Ravanini P, Avolio M, Cavallo R, Bertolotti L, Felici E, Acucella G, Montin D, Rabbone I, Licciardi F. All that glisters is not COVID: Low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with chilblain-like lesions. J Am Acad Dermatol 2020;83:1751-3. [PMID: 32781180 DOI: 10.1016/j.jaad.2020.08.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
90 Colmenero I, Santonja C, Alonso-Riaño M, Noguera-Morel L, Hernández-Martín A, Andina D, Wiesner T, Rodríguez-Peralto JL, Requena L, Torrelo A. SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases. Br J Dermatol 2020;183:729-37. [PMID: 32562567 DOI: 10.1111/bjd.19327] [Cited by in Crossref: 179] [Cited by in F6Publishing: 158] [Article Influence: 89.5] [Reference Citation Analysis]
91 Ladha MA, Luca N, Constantinescu C, Naert K, Ramien ML. Approach to Chilblains During the COVID-19 Pandemic [Formula: see text]. J Cutan Med Surg 2020;24:504-17. [PMID: 32741218 DOI: 10.1177/1203475420937978] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
92 Buhl T, Beissert S, Gaffal E, Goebeler M, Hertl M, Mauch C, Reich K, Schmidt E, Schön MP, Sticherling M, Sunderkötter C, Traidl-Hoffmann C, Werfel T, Wilsman-Theis D, Worm M. COVID-19 and implications for dermatological and allergological diseases. J Dtsch Dermatol Ges 2020;18:815-24. [PMID: 32717116 DOI: 10.1111/ddg.14195] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
93 Navarro L, Andina D, Noguera-Morel L, Hernández-Martín A, Colmenero I, Torrelo A. Dermoscopy features of COVID-19-related chilblains in children and adolescents. J Eur Acad Dermatol Venereol 2020;34:e762-4. [PMID: 32618033 DOI: 10.1111/jdv.16800] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
94 Gisondi P, PIaserico S, Bordin C, Alaibac M, Girolomoni G, Naldi L. Cutaneous manifestations of SARS-CoV-2 infection: a clinical update. J Eur Acad Dermatol Venereol 2020;34:2499-504. [PMID: 32585074 DOI: 10.1111/jdv.16774] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 14.5] [Reference Citation Analysis]
95 Mohan V, Lind R. Chilblains in COVID-19 Infection. Cureus 2020;12:e9245. [PMID: 32821591 DOI: 10.7759/cureus.9245] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
96 Visveswaran GK, Morparia K, Narang S, Sturt C, Divita M, Voigt B, Hawatmeh A, McQueen D, Cohen M. Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Thrombosis: Phlegmasia Cerulea Dolens Presenting with Venous Gangrene in a Child. J Pediatr 2020:S0022-3476(20)30875-1. [PMID: 32673617 DOI: 10.1016/j.jpeds.2020.07.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
97 Torrelo A, Andina D, Santonja C, Noguera-Morel L, Bascuas-Arribas M, Gaitero-Tristán J, Alonso-Cadenas JA, Escalada-Pellitero S, Hernández-Martín Á, de la Torre-Espi M, Colmenero I. Erythema multiforme-like lesions in children and COVID-19. Pediatr Dermatol 2020;37:442-6. [PMID: 32445583 DOI: 10.1111/pde.14246] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 26.0] [Reference Citation Analysis]
98 Rajapakse N, Dixit D. Human and novel coronavirus infections in children: a review. Paediatr Int Child Health 2021;41:36-55. [PMID: 32584199 DOI: 10.1080/20469047.2020.1781356] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 8.0] [Reference Citation Analysis]
99 Bristow IR, Borthwick AM. The mystery of the COVID toes - turning evidence-based medicine on its head. J Foot Ankle Res 2020;13:38. [PMID: 32576291 DOI: 10.1186/s13047-020-00408-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
100 Damsky W, Peterson D, King B. When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection. J Am Acad Dermatol 2020;83:e269-70. [PMID: 32565206 DOI: 10.1016/j.jaad.2020.06.052] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 10.0] [Reference Citation Analysis]
101 Hilal El Idrissi H. COVID-19: What you need to know. Gene Rep 2020;20:100756. [PMID: 33521383 DOI: 10.1016/j.genrep.2020.100756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
102 Colonna C, Genovese G, Monzani NA, Picca M, Boggio F, Gianotti R, Marzano AV. Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic. J Am Acad Dermatol 2020;83:965-9. [PMID: 32534082 DOI: 10.1016/j.jaad.2020.06.019] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
103 Lipsker D. A chilblain epidemic during the COVID-19 pandemic. A sign of natural resistance to SARS-CoV-2? Med Hypotheses 2020;144:109959. [PMID: 32534339 DOI: 10.1016/j.mehy.2020.109959] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
104 Zaladonis A, Huang S, Hsu S. COVID toes or pernio? Clin Dermatol 2020;38:764-7. [PMID: 33341212 DOI: 10.1016/j.clindermatol.2020.06.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
105 Massey PR, Jones KM. Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic. Semin Oncol 2020;47:330-4. [PMID: 32736881 DOI: 10.1053/j.seminoncol.2020.05.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
106 Andina D, Noguera-Morel L, Bascuas-Arribas M, Gaitero-Tristán J, Alonso-Cadenas JA, Escalada-Pellitero S, Hernández-Martín Á, de la Torre-Espi M, Colmenero I, Torrelo A. Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol 2020;37:406-11. [PMID: 32386460 DOI: 10.1111/pde.14215] [Cited by in Crossref: 98] [Cited by in F6Publishing: 88] [Article Influence: 49.0] [Reference Citation Analysis]